These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 17889361)
1. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts. Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361 [TBL] [Abstract][Full Text] [Related]
2. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients. Yoo KH; Lee SH; Kim HJ; Sung KW; Jung HL; Cho EJ; Park HK; Kim HA; Koo HH Bone Marrow Transplant; 2007 May; 39(9):515-21. PubMed ID: 17334379 [TBL] [Abstract][Full Text] [Related]
3. Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment. Yang H; Acker JP; Cabuhat M; Letcher B; Larratt L; McGann LE Bone Marrow Transplant; 2005 May; 35(9):881-7. PubMed ID: 15778729 [TBL] [Abstract][Full Text] [Related]
4. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation. Kim DH; Won DI; Lee NY; Sohn SK; Suh JS; Lee KB Biol Blood Marrow Transplant; 2006 Jul; 12(7):719-28. PubMed ID: 16785061 [TBL] [Abstract][Full Text] [Related]
5. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors. Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993 [TBL] [Abstract][Full Text] [Related]
6. Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation. Mahmut N; Katayama Y; Takenaka K; Teshima T; Ohno Y; Imajyo K; Hara M; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M Int J Hematol; 1999 Jan; 69(1):36-42. PubMed ID: 10641441 [TBL] [Abstract][Full Text] [Related]
7. Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors. Allan DS; Dubé P; Roy J; Busque L; Roy DC Biol Blood Marrow Transplant; 2007 Apr; 13(4):433-9. PubMed ID: 17382249 [TBL] [Abstract][Full Text] [Related]
8. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells. Ozdemir E; Akgedik K; Akdogan S; Kansu E Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066 [TBL] [Abstract][Full Text] [Related]
9. Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant. Kanamaru S; Kawano Y; Watanabe T; Nakagawa R; Suzuya H; Onishi T; Yamazaki J; Nakayama T; Kuroda Y; Takaue Y Stem Cells; 2000; 18(3):190-5. PubMed ID: 10840072 [TBL] [Abstract][Full Text] [Related]
10. Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation. Yang H; Acker JP; Cabuhat M; McGann LE Bone Marrow Transplant; 2003 Nov; 32(10):1021-6. PubMed ID: 14595390 [TBL] [Abstract][Full Text] [Related]
11. Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors. Kim DH; Sohn SK; Lee NY; Baek JH; Kim JG; Won DI; Suh JS; Lee KB; Shin IH Eur J Haematol; 2005 Oct; 75(4):299-308. PubMed ID: 16146536 [TBL] [Abstract][Full Text] [Related]
12. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation. Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430 [TBL] [Abstract][Full Text] [Related]
13. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation. Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260 [TBL] [Abstract][Full Text] [Related]
14. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF; Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063 [TBL] [Abstract][Full Text] [Related]
15. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report. Cairo MS; Wagner EL; Fraser J; Cohen G; van de Ven C; Carter SL; Kernan NA; Kurtzberg J Transfusion; 2005 Jun; 45(6):856-66. PubMed ID: 15934982 [TBL] [Abstract][Full Text] [Related]
16. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation. Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331 [TBL] [Abstract][Full Text] [Related]
17. Analysis of parameters affecting engraftment in children undergoing allogeneic BM transplants. Kletzel M; Haut PR; Olzewski M; Figuerres E Cytotherapy; 1999; 1(5):417-22. PubMed ID: 20443234 [TBL] [Abstract][Full Text] [Related]
18. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment. Beaujean F; Bourhis JH; Bayle C; Jouault H; Divine M; Rieux C; Janvier M; Le Forestier C; Pico JL Bone Marrow Transplant; 1998 Dec; 22(11):1091-6. PubMed ID: 9877272 [TBL] [Abstract][Full Text] [Related]
19. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079 [TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children. Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]